Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription

  • Wierer, Michael, 1982-
  • Verde, Gaetano
  • Pisano, Paola
  • Molina, Henrik
  • Font Mateu, Jofre, 1977-
  • Di Croce, Luciano
  • Beato, Miguel
Polo-like kinase 1 (PLK1) is a key regulator of cell division and is overexpressed in many types of human cancers. Compared to its well-characterized role in mitosis, little is known about PLK1 functions in interphase. Here, we report that PLK1 mediates estrogen receptor (ER)-regulated gene transcription in human breast cancer cells. PLK1 interacts with ER and is recruited to ER cis-elements on chromatin. PLK1-coactivated genes included classical ER target genes such as Ps2, Wisp2, and Serpina3 and were enriched in developmental and tumor-suppressive functions. Performing large-scale phosphoproteomics of estradiol-treated MCF7 cells in the presence or absence of the specific PLK1 inhibitor BI2536, we identified several PLK1 end targets involved in transcription, including the histone H3K4 trimethylase MLL2, the function of which on ER target genes was impaired by PLK1 inhibition. Our results propose a mechanism for the tumor-suppressive role of PLK1 in mammals as an interphase transcriptional regulator., We would like to thank Thorsten Berg for kindly providing the Poloxin compound; Johan Staaf for the preprocessed 1,881-sample breast tumor data set; Giancarlo Castellano, Sarah Bonnin, and Andrew Pohl for bioinformatic support; Alessandra Ciociola and Roni Wright for experimental help; and Juan Valcarcel for critically reading the manuscript. Mass spectrometry, microarray, and cell sorting analyses were performed at the UPF/CRG proteomic, microarray, and flow cytometry core facilities, respectively. G.V. has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 299429 and from the European Molecular Biology Organization (EMBO long-term fellowship ALTF 1106-2011, cofunded with the European Commission EMBOCOFUND2010, GA-2010-267146). This study was supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC), and the Catalan government (AGAUR).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Nucleosome-driven transcription factor binding and gene regulation

  • Ballaré, Cecilia Julia
  • Castellano, Giancarlo
  • Gaveglia, Laura
  • Althammer, Sonja Daniela
  • González-Vallinas Rostes, Juan, 1983-
  • Eyras Jiménez, Eduardo
  • Le Dily, François
  • Zaurín Quer, Roser
  • Soronellas, Daniel
  • Vicent, Guillermo P.
  • Beato, Miguel
In fission yeast cells, Cds1 is the effector kinase of the DNA replication checkpoint. We previously showed that when the DNA replication checkpoint is activated, the repressor Yox1 is phosphorylated and inactivated by Cds1, resulting in activation of MluI-binding factor (MBF)-dependent transcription. This is essential to reinitiate DNA synthesis and for correct G1-to-S transition. Here we show that Cdc10, which is an essential part of the MBF core, is the target of the DNA damage checkpoint. When fission yeast cells are treated with DNA-damaging agents, Chk1 is activated and phosphorylates Cdc10 at its carboxy-terminal domain. This modification is responsible for the repression of MBF-dependent transcription through induced release of MBF from chromatin. This inactivation of MBF is important for survival of cells challenged with DNA-damaging agents. Thus Yox1 and Cdc10 couple normal cell cycle regulation in unperturbed conditions and the DNA replication and DNA damage checkpoints into a single transcriptional complex., The experimental work was supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC), and the Catalan government (AGAUR). L.G. was a recipient of a fellowship from the International PhD program of LaCaixa; G.P.V. was a recipient of a fellowship from the Ramón y Cajal program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Nucleosome-driven transcription factor binding and gene regulation

  • Ballaré, Cecilia Julia
  • Castellano, Giancarlo
  • Gaveglia, Laura
  • Althammer, Sonja Daniela
  • González-Vallinas Rostes, Juan, 1983-
  • Eyras Jiménez, Eduardo
  • Le Dily, François
  • Zaurín Quer, Roser
  • Soronellas, Daniel
  • Vicent, Guillermo P.
  • Beato, Miguel
In fission yeast cells, Cds1 is the effector kinase of the DNA replication checkpoint. We previously showed that when the DNA replication checkpoint is activated, the repressor Yox1 is phosphorylated and inactivated by Cds1, resulting in activation of MluI-binding factor (MBF)-dependent transcription. This is essential to reinitiate DNA synthesis and for correct G1-to-S transition. Here we show that Cdc10, which is an essential part of the MBF core, is the target of the DNA damage checkpoint. When fission yeast cells are treated with DNA-damaging agents, Chk1 is activated and phosphorylates Cdc10 at its carboxy-terminal domain. This modification is responsible for the repression of MBF-dependent transcription through induced release of MBF from chromatin. This inactivation of MBF is important for survival of cells challenged with DNA-damaging agents. Thus Yox1 and Cdc10 couple normal cell cycle regulation in unperturbed conditions and the DNA replication and DNA damage checkpoints into a single transcriptional complex., The experimental work was supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC), and the Catalan government (AGAUR). L.G. was a recipient of a fellowship from the International PhD program of LaCaixa; G.P.V. was a recipient of a fellowship from the Ramón y Cajal program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription

  • Wierer, Michael, 1982-
  • Verde, Gaetano
  • Pisano, Paola
  • Molina, Henrik
  • Font Mateu, Jofre, 1977-
  • Di Croce, Luciano
  • Beato, Miguel
Polo-like kinase 1 (PLK1) is a key regulator of cell division and is overexpressed in many types of human cancers. Compared to its well-characterized role in mitosis, little is known about PLK1 functions in interphase. Here, we report that PLK1 mediates estrogen receptor (ER)-regulated gene transcription in human breast cancer cells. PLK1 interacts with ER and is recruited to ER cis-elements on chromatin. PLK1-coactivated genes included classical ER target genes such as Ps2, Wisp2, and Serpina3 and were enriched in developmental and tumor-suppressive functions. Performing large-scale phosphoproteomics of estradiol-treated MCF7 cells in the presence or absence of the specific PLK1 inhibitor BI2536, we identified several PLK1 end targets involved in transcription, including the histone H3K4 trimethylase MLL2, the function of which on ER target genes was impaired by PLK1 inhibition. Our results propose a mechanism for the tumor-suppressive role of PLK1 in mammals as an interphase transcriptional regulator., We would like to thank Thorsten Berg for kindly providing the Poloxin compound; Johan Staaf for the preprocessed 1,881-sample breast tumor data set; Giancarlo Castellano, Sarah Bonnin, and Andrew Pohl for bioinformatic support; Alessandra Ciociola and Roni Wright for experimental help; and Juan Valcarcel for critically reading the manuscript. Mass spectrometry, microarray, and cell sorting analyses were performed at the UPF/CRG proteomic, microarray, and flow cytometry core facilities, respectively. G.V. has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 299429 and from the European Molecular Biology Organization (EMBO long-term fellowship ALTF 1106-2011, cofunded with the European Commission EMBOCOFUND2010, GA-2010-267146). This study was supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC), and the Catalan government (AGAUR).